The article presents the case of clinical observation of a child with atypical hemolytic uremic syndrome, who is on therapy with eculizumab. The clinical picture of the disease is described; the results of a comprehensive examination of the patient, the dynamics of clinical and laboratory data on the background of treatment are given.

Keywords: Atypical hemolytic uremic syndrome, Eculizumab, children